World Heart Day- Revisiting Metoprolol's Contribution to Cardiology - Video

Published On 2024-09-30T08:45:15+05:30 | Updated On 30 Sept 2024 2:18 PM IST

Overview

This month, on September 29, 2024, as we celebrate World Heart Day, lets dive into the contribution of an age-old and trusted molecule Metoprolol, in the field of cardiology. Just last month, in August 2024, we marked the 46th anniversary of Metoprolol's approval.

Metoprolol has remained a resourceful pharmacological agent in cardiology practice in India. It has stood the test of scientific excellence, with robust real-world experience, and remains a valuable life-saving agent.

Joining us in today's discussion at the Medical Dialogues Show, we have with us Dr. Dilip Kumar, Senior Consultant Interventional Cardiologist and Electrophysiologist, Director of Cardiac Cath Lab, and Chief Academic Coordinator at Medica Institute of Cardiac Sciences.

He shares his insights on:

1. What are your thoughts on the robust legacy of Metoprolol in cardiology?

2. Which indications would you like to consider Metoprolol in cardiology?

3. As per a recently published 2024 expert opinion from Indian cardiologists; among beta-blockers, metoprolol is the first treatment choice for post-PCI and heart failure patients. What makes it such a special beta-blocker in India?

4. Another Indian study published earlier highlighted Metoprolol as the preferred BB for hypertension management in young adults. What is your take on it?

5. Any special Metoprolol anecdote from your vast clinical practice journey that comes to your mind and you may like to share with medical fraternity friends?

Speakers

Dr. Dilip Kumar

Dr Dilip Kumar MBBS, MD(Medicine), DM(Cardiology), FACC, FRCP (GLAS), FSCAI, FESC, FICC, FHRS. He is a well-known Interventional Cardiologist and Structural Heart Expert. He currently serves as the Senior Consultant Interventional Cardiologist & Electrophysiologist and Director of Cardiac Cath Lab Services at Medica Institute of Cardiac Sciences, Kolkata.

Dr. Nandita Mohan

BDS, MDS( Pedodontics and Preventive Dentistry)

Dr. Nandita Mohan is a practicing pediatric dentist with more than 5 years of clinical work experience. Along with this, she is equally interested in keeping herself up to date about the latest developments in the field of medicine and dentistry which is the driving force for her to be in association with Medical Dialogues. She also has her name attached with many publications; both national and international. She has pursued her BDS from Rajiv Gandhi University of Health Sciences, Bangalore and later went to enter her dream specialty (MDS) in the Department of Pedodontics and Preventive Dentistry from Pt. B.D. Sharma University of Health Sciences. Through all the years of experience, her core interest in learning something new has never stopped. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751